Patent Monopolies Drive Record Profits
Novo Nordisk and Eli Lilly have transformed GLP-1 receptor agonists into unprecedented profit machines. These blockbuster drugs, approved for diabetes and weight loss, generate billions while leaving many patients unable…
What You Should Know:
– Photon Health (“Photon”), a prescription network focused on patient choice and transparency announced a collaboration with Amazon Pharmacy, the digital-first online pharmacy known for price transparency and medication access.
– The…
Continue Reading
Transforming Electronic Prescribing Through Price Transparency
DoseSpot, a leading electronic prescribing platform, is revolutionizing how patients access their medications with the launch of DoseSpot Connect. This innovative product suite represents a significant leap forward in…
Yoona Kim, Founder & CEO at Arine
As ultra-fast prescription delivery services reshape medication access, healthcare providers face an urgent challenge: balancing patient convenience with medication safety. With 1 in 5 adults using five or…
Continue Reading
Patty Trainor, Sr. Director KS&R
Infusion Clinics (ICs) face a delicate balancing act. They must strive for operational excellence while simultaneously navigating the realities of competition, patient care challenges, and compliance requirements. It’s a difficult…
Continue Reading
What You Should Know:
–TailorMed, a leading innovator in healthcare technology, announced a $40 million financing round combining equity and debt. This investment positions the company to advance its bold vision of transforming medication access,…
Continue Reading
From Jaded CMIO: “Re your recent comments about the Medication Access and Training Expansion Act (MATE) and its 8-hour DEA education requirement being a time waster. I’m in the same boat – I don’t…
Continue Reading
Truveris, a health technology company focused on decreasing prescription costs for employers and their members, announced it secured $15 million in Series E investment. Existing investors Canaan Partners and New Leaf Venture Partners led the…
Continue Reading
By Anuja Vaidya
March 06, 2024 – Regulatory flexibilities enabling virtual initiation and at-home doses of medications for opioid use disorder (OUD) are likely cost-effective, according to new research.
Published in the journal Drug and Alcohol Dependence,…
Continue Reading
By Sara Heath
December 15, 2023 – About a million Medicare enrollees have opioid use disorder (OUD), but only 18 percent of them received medication to treat OUD, according to a new Office of Inspector General…
Continue Reading
